Canada Pension Plan Investment Board’s Axsome Therapeutics AXSM Stock Holding History

Canada Pension Plan Investment Board’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.4M	Sell	91,400 -11,800	-11%	-$2.04M	0.01%	545
2025 Q4	$18.8M	Buy	103,200 +38,800	+60%	+$5.42M	0.01%	520
2025 Q3	$7.82M	Sell	64,400 -7,900	-11%	-$890K	0.01%	686
2025 Q2	$7.55M	Buy	72,300 +27,800	+62%	+$2.94M	0.01%	642
2025 Q1	$5.19M	Buy	44,500 +40,400	+985%	+$4.6M	0.01%	680
2024 Q4	$347K	Buy	+4,100	New	+$377K	﹤0.01%	1126
2020 Q3	–	Sell	-2,100	Closed	-$173K	–	1105
2020 Q2	$173K	Buy	+2,100	New	+$162K	﹤0.01%	1218

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board's AXSM Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Axsome Therapeutics (AXSM) stake by 11% in Q1 2026, selling an estimated $2.04M and leaving 91,400 shares worth $15.4M. The position accounts for 0.01% of the portfolio, ranked #545.

Canada Pension Plan Investment Board first reported a position in AXSM in Q2 2020 and has held it in 7 quarters since. The position peaked at $18.8M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Canada Pension Plan Investment Board held 91,400 shares of Axsome Therapeutics worth $15.4M as of Q1 2026.
Canada Pension Plan Investment Board sold 11,800 Axsome Therapeutics shares in Q1 2026, an estimated $2.04M.
Axsome Therapeutics made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #545 holding.
Canada Pension Plan Investment Board first reported a position in Axsome Therapeutics in Q2 2020 and has held it in 7 quarters since.
Canada Pension Plan Investment Board's Axsome Therapeutics position peaked at $18.8M in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.